SMITH & NEWPHEW,

AND OTHER HIP IMPLANT MANUFACTURERS,

HAVE AGREED TO PAY

BILLIONS OF DOLLARS

IN SETTLEMENTS TO COMPENSATE VICTIMS.

• The following Smith & Nephew hip implants have been recalled:
  • REDAPT Hip Systems – Recalled in 2016: In late 2016, Smith & Nephew issued a recall on its Modular REDAPT Hip Systems “due to a higher than anticipated complaint and adverse event trend” with the design of the device.
  • Birmingham Hip Resurfacing System – Recalled in 2015: In June of 2015, Smith & Nephew issued a recall of the smaller sized components of its Birmingham Hip Resurfacing System. The company discovered that patients with this system had revision rates that exceeded certain benchmarks. Based on this, Smith & Nephew considered these patients to be at a higher risk of revision surgery and removed these products from the market.
  • R3 Acetabular System – Recalled in 2012: The R3 Acetabular System was recalled worldwide in 2012 because of reports of device failure, pain, metal sensitivity and other complications.
  • Emperion Modular Hip System – Not yet recalled: While it has not been recalled, the FDA also received numerous adverse event reports concerning Smith & Nephew’s Emperion Modular Hip System. These reports include patients suffering fractures of their hip implants and needing painful revision surgeries.

• SERIOUS COMPLICATIONS from Metal-on-Metal hip implants can include:

• • Implant Failure
  • Need for Revision Surgery
  • Elevated levels of cobalt and/or chromium in the blood
  • Diagnosis of metallosis
  • Loosening of the device
• It has been reported that metal-on-metal hip replacements have the highest failure rate and fail at a rate of over 10%; meaning that many patients will need to endure costly and painful revision surgery.
• Juries have also awarded plaintiffs hundreds of millions of dollars in some recent trials.